Catalase-loaded nanogels engineered for inhalation efficiently scavenge ROS in the airways, normalize the balance between phosphorylated and total NF-κB p65, inhibit the NLRP3 inflammasome, and reduce both inflammatory cytokines and bacterial burden in a neutrophil-driven asthma model [121]. The gene discussed is NFKB1; the disease is asthma.